Telangana government has set up a medical devices manufacturing park at Sultanpur in the state. The manufacturing park spread over 250 acres is touted to be the largest facility in India for medical devices and electronics and will focus on medical innovations, R&D and manufacturing. Currently, 14 companies have set up production facility in the park with an investment of Rs.4250 million. Apollo Hospitals and Cyient are among the initial movers into the medical devices park. The park has also signed with China Medical City located at Taizhou, and Medical Devices Park located in Gwangju in South Korea for exchange of knowledge
National Pharmaceutical Pricing Authority has revised the price of stents in India, reducing it by over 75%. The price of stent has been capped at Rs 7,260, whereas both drugeluting stents (DES) and biodegradable stents will now cost Rs 29,600. It has also mandated institutions to disclose separately the cost of the stent while billing a patient. Medical facilities, including retailers and dealers of stents, will also have to display price list of stents on a part of their premises which is easily accessible to any person wishing to consult the same.
Government of India has notified a new Medical Devices Rules, 2017 which classify devices based on the risks associated with them. This move will facilitate growth and remove unnecessary encumbrance involved in licensing process. The new rules, which classify devices according to the risk levels, allow the authorities to grant licences without any audit of the manufacturing site for devices with the lower risk.
The manufacturer can do self-certification of compliance with the requirements and based on such certification the license may be issued. The four classes of devices will be based on risk level ? low (class A), low moderate (B), moderate high (C) and high (D).
At present, only 15 devices are regulated under the classification of drugs. The medical devices industry has been pushing f